{"version":"1.0","type":"link","title":"[Clinical efficacy and safety of CLAE regimen for refractory/relapsed T cell acute lymphoblastic leukemia/lymphoma: a prospective, multicenter, single-arm study].","author_name":"Li Y 외","author_url":"https://prs-insight.online/author/Li%20Y","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/166279","thumbnail_width":1200,"thumbnail_height":630}